ESC 365 - Reduction of mitral regurgitation in patients with heart failure and secondary mitral regurgitation: relationship between changes in brain natriuretic peptide and outcomes from the COAPT trial

ESC Premium Access

Reduction of mitral regurgitation in patients with heart failure and secondary mitral regurgitation: relationship between changes in brain natriuretic peptide and outcomes from the COAPT trial

Session: From trials to clinical use: transcatheter interventions in secondary mitral regurgitation

Topic: Intervention

Speaker: Doctor G. Stone (New York, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Gregg Stone

Icahn School of Medicine at Mount Sinai, New York (United States of America)

20 presentations

2 followers

4 more presentations in this session

State of the Art - Review of current evidence for transcatheter interventions in secondary mitral regurgitation

Speaker: Professor S. Kapadia (Cleveland, US)

MitraClip treatment of functional mitral regurgitation - A meta-analysis

Speaker: Assistant Professor M. Noutsias (Neuruppin, DE)

Combined tricuspid and mitral vs. isolated mitral valve repair for severe mitral and tricuspid regurgitation: An analysis from TriValve and TRAMI registries

Speaker: Mr M. Mehr (Munich, DE)

Surgical vs. catheter-based treatment of mitral regurgitation in 2030

Speaker: Professor F. Maisano (Milan, IT)

Access the full session

From trials to clinical use: transcatheter interventions in secondary mitral regurgitation

Speakers: Doctor G. Stone, Professor S. Kapadia, Assistant Professor M. Noutsias, Mr M. Mehr, Professor F. Maisano

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources